The proteasome and the degradation of oxidized proteins: Part III-Redox regulation of the proteasomal system

Redox Biology

Volumn 2, Issue 1, 2014, Pages 388-394

  Höhn, Tobias Jung Annika ^a   Grune, Tilman ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

20S proteasome; Jak Stat; Nrf2; PARP1; Ubiquitin proteasome system

Indexed keywords

20S PROTEASOME; ADENOSINE TRIPHOSPHATASE; PROTEASOME; PROTEOME; REGULATOR PROTEIN; TRANSCRIPTION FACTOR NRF2; UBIQUITIN; UNCLASSIFIED DRUG; JANUS KINASE; NFE2L2 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; STAT PROTEIN;

CELL METABOLISM; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; UBIQUITINATION; ANIMAL; CHEMICAL STRUCTURE; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION;

ANIMALS; HUMANS; JANUS KINASES; MODELS, MOLECULAR; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEOLYSIS; STAT TRANSCRIPTION FACTORS; UBIQUITIN;

EID: 84896732643     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.12.029     Document Type: Review

References (55)

1. Jung T., Grune T. The proteasome and the degradation of oxidized proteins: Part I-Structure of proteasomes. Redox Biol. 2013, 1:178-182.
2. Jung T., Catalgol B., Grune T. The proteasomal system. Mol. Aspects Med. 2009, 30:191-296.
3. Jung T., Höhn A., Grune T. The proteasome and the degradation of oxidized proteins: Part II - protein oxidation and proteasomal degradation. Redox Biol. 2014, 2:99-104.
4. Sies H. Oxidative stress: from basic research to clinical application. Am. J. Med. 1991, 91:31S-38.
5. Jones D.P. Redefining oxidative stress. Antioxid. Redox Signal. 2006, 8:1865-1879.
6. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 1999, 274:23787-23793.
7. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K.J., Grune T. Comperative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 1998, 335:637-642.
8. Reinheckel T., Ullrich O., Sitte N., Grune T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch. Biochem. Biophys. 2000, 377:65-68.
9. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013, 1:45-49.
10. Obin M., Shang F., Gong X., Handelman G., Blumberg J., Taylor A. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J. 1998, 12:561-569.
11. Shang F., Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radical Biol. Med. 2011, 51:5-16.
12. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., Davies K.J. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Nat. Acad. Sci. U.S.A. 1999, 96:6223-6228.
13. Catalgol B., Wendt B., Grimm S., Breusing N., Ozer N.K., Grune T. Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation. Free Radical Biol. Med. 2010, 48:673-680.
14. Sledz P., Unverdorben P., Beck F., Pfeifer G., Schweitzer A., Forster F., et al. Structure of the 26S proteasome with ATP-gammaS bound provides insights into the mechanism of nucleotide-dependent substrate translocation. Proc. Nat. Acad. Sci. U.S.A. 2013, 110:7264-7269.
15. Farout L., Mary J., Vinh J., Szweda L.I., Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch. Biochem. Biophys. 2006, 453:135-142.
16. Ferrington D.A., Kapphahn R.J. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett. 2004, 578:217-223.
17. Hyun D.H., Lee M.H., Halliwell B., Jenner P. Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration?. J. Neurochem. 2002, 83:360-370.
18. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 1999, 274:23787-23793.
19. Shringarpure R., Grune T., Sitte N., Davies K.J. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell. Mol. Life Sci. 2000, 57. (1802-9).
20. Ishii T., Sakurai T., Usami H., Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26S proteasome. Biochemistry 2005, 44:13893-13901.
21. Silva G.M., Netto L.E., Simoes V., Santos L.F., Gozzo F.C., Demasi M.A., et al. Redox control of 20S proteasome gating. Antioxid. Redox Signal. 2012, 16:1183-1194.
22. Zmijewski J.W., Banerjee S., Abraham E. S-glutathionylation of the Rpn2 regulatory subunit inhibits 26S proteasomal function. J. Biol. Chem. 2009, 284:22213-22221.
23. Rosenzweig R., Bronner V., Zhang D., Fushman D., Glickman M.H. Rpn1 and Rpn2 coordinate ubiquitin processing factors at proteasome. J. Biol. Chem. 2012, 287:14659-14671.
24. Jahngen-Hodge J., Obin M.S., Gong X., Shang F., Nowell T.R., Gong J., et al. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 1997, 272:28218-28226.
25. Zong C., Young G.W., Wang Y., Lu H., Deng N., Drews O., et al. Two-dimensional electrophoresis-based characterization of post-translational modifications of mammalian 20S proteasome complexes. Proteomics 2008, 8:5025-5037.
26. Queisser M.A., Yao D., Geisler S., Hammes H.P., Lochnit G., Schleicher E.D., et al. Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 2010, 59:670-678.
27. Katoh Y., Iida K., Kang M.I., Kobayashi A., Mizukami M., Tong K.I., et al. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch. Biochem. Biophys. 2005, 433:342-350.
28. Chapple S.J., Siow R.C., Mann G.E. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int. J. Biochem. Cell Biol. 2012, 44:1315-1320.
29. Theodore M., Kawai Y., Yang J., Kleshchenko Y., Reddy S.P., Villalta F., et al. Multiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2. J. Biol. Chem. 2008, 283:8984-8994.
30. Giudice A., Arra C., Turco M.C. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol. Biol. 2010, 647:37-74.
31. Kwak M.K., Wakabayashi N., Greenlaw J.L., Yamamoto M., Kensler T.W. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell. Biol. 2003, 23:8786-8794.
32. Pickering A.M., Linder R.A., Zhang H., Forman H.J., Davies K.J. Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J. Biol. Chem. 2012, 287:10021-10031.
33. Grimm S., Ott C., Horlacher M., Weber D., Hohn A., Grune T. Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1. Biochem. J. 2012, 448:127-139.
34. Bose S., Stratford F.L., Broadfoot K.I., Mason G.G., Rivett A.J. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem. J. 2004, 378:177-184.
35. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
36. Gomez-Lucia E., Collado V.M., Miro G., Domenech A. Effect of type-I interferon on retroviruses. Viruses 2009, 1:545-573.
37. Jung T., Hohn A., Catalgol B., Grune T. Age-related differences in oxidative protein-damage in young and senescent fibroblasts. Arch. Biochem. Biophys. 2009, 483:127-135.
38. Jung T., Bader N., Grune T. Oxidized proteins: intracellular distribution and recognition by the proteasome. Arch. Biochem. Biophys. 2007, 462:231-237.
39. Jung T., Engels M., Klotz L.O., Kroncke K.D., Grune T. Nitrotyrosine and protein carbonyls are equally distributed in HT22 cells after nitrosative stress. Free Radical Biol. Med. 2007, 42:773-786.
40. Jung T., Engels M., Kaiser B., Poppek D., Grune T. Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. Free Radical Biol. Med. 2006, 40:1303-1312.
41. De V.M., Schreiber V., Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem. Pharmacol. 2012, 84:137-146.
42. Abeti R., Duchen M.R. Activation of PARP by oxidative stress induced by beta-amyloid: implications for Alzheimer's disease. Neurochem. Res. 2012, 37:2589-2596.
43. Arnold J., Grune T. PARP-mediated proteasome activation: a co-ordination of DNA repair and protein degradation?. Bioessays 2002, 24:1060-1065.
44. Bakondi E., Catalgol B., Bak I., Jung T., Bozaykut P., Bayramicli M., et al. Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity. Free Radical Biol. Med. 2011, 50:86-92.
45. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., von Z.T., et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 2000, 14:1490-1498.
46. Hohn A., Grune T. Lipofuscin: formation, effects and role of macroautophagy. Redox Biol. 2013, 1:140-144.
47. Hohn A., Jung T., Grimm S., Catalgol B., Weber D., Grune T. Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radical Biol. Med. 2011, 50:585-591.
48. Grune T., Jung T., Merker K., Davies K.J. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 2004, 36:2519-2530.
49. Grune T., Reinheckel T., Davies K.J.A. Degradation of oxidized proteins in mammalian cells. FASEB J. 1997, 11:526-534.
50. Ullrich O., Ciftci O., Hass R. Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress. Free Radical Biol. Med. 2000, 29:995-1004.
51. Ciftci O., Ullrich O., Schmidt C.A., Diestel A., Hass R. Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood 2001, 97:2830-2838.
52. Mayer-Kuckuk P., Ullrich O., Ziegler M., Grune T., Schweiger M. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro. Biochem. Biophys. Res. Commun. 1999, 259:576-581.
53. Ullrich O., Diestel A., Bechmann I., Homberg M., Grune T., Hass R., et al. Turnover of oxidatively damaged nuclear proteins in BV-2 microglial cells is linked to their activation state by poly-ADP-ribose polymerase. FASEB J. 2001, 15:1460-1462.
54. Grune T., Catalgol B., Licht A., Ermak G., Pickering A.M., Ngo J.K., et al. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radical Biol. Med. 2011, 51:1355-1364.
55. Pickering A.M., Davies K.J. Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins. Arch. Biochem. Biophys. 2012, 523:181-190.